Publication:
Fibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma.

Simple item page
dc.contributor.authorKAYA, HATEM
dc.contributor.authorDEMIR, MUSA
dc.contributor.authorTAYLAN, M
dc.contributor.authorSEZGI, C
dc.contributor.authorTANRIKULU, AC
dc.contributor.authorYILMAZ, SİNAN
dc.contributor.authorBayram, MEHMET
dc.contributor.authorKAPLAN, I
dc.contributor.authorSENYIGIT, A
dc.contributor.institutionauthorKAYA, HATEM
dc.contributor.institutionauthorDEMİR, MUSA
dc.contributor.institutionauthorYILMAZ, SİNAN
dc.contributor.institutionauthorBAYRAM, MEHMET
dc.date.accessioned2019-10-05T13:44:42Z
dc.date.available2019-10-05T13:44:42Z
dc.date.issued2015-01-01
dc.identifier
dc.identifier.citationKAYA H., DEMIR M., TAYLAN M., SEZGI C., TANRIKULU A., YILMAZ S., Bayram M., KAPLAN I., SENYIGIT A., -Fibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma.-, Asian Pacific journal of cancer prevention : APJCP, cilt.16, ss.1403-7, 2015
dc.identifier.doi10.7314/apjcp.2015.16.4.1403
dc.identifier.scopus84926135762
dc.identifier.urihttps://hdl.handle.net/20.500.12645/2877
dc.language.isoen
dc.titleFibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma.
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameActa Pharm. Turc
local.avesis.id45cedbbe-3702-40b8-8970-4e08900474a1
local.avesis.response2747
local.publication.isinternational1
relation.isAuthorOfPublication0c4a7045-1d34-4490-a2c8-bcf116d83c86
relation.isAuthorOfPublicatione83c9f29-edac-4889-bf90-d34ead74670b
relation.isAuthorOfPublicationa6d0cb1c-2467-4748-8e74-2c3952621d77
relation.isAuthorOfPublication6df71d2f-97bd-4028-88d7-8384cb4bf22f
relation.isAuthorOfPublication.latestForDiscovery6df71d2f-97bd-4028-88d7-8384cb4bf22f
Files
Collections
Silinecekler